Recurrence in complete responders after trimodality therapy in esophageal cancer

Complete pathological response (pCR) remains one of the most important prognostic factors of long-term survival in esophageal cancer (EC) and gastro-esophageal junction (GEJ) after trimodality treatment including neoadjuvant chemoradiotherapy (CRT) followed by surgery.